Novartis (Austria)

About

In recent decades, authors affiliated with Novartis (Austria) have published 548 papers, which have received a total of 32.4k indexed citations. Scholars at this organization have produced 253 papers in Molecular Biology, 186 papers in Immunology and 69 papers in Organic Chemistry on the topics of T-cell and B-cell Immunology (79 papers), Sphingolipid Metabolism and Signaling (61 papers) and Immune Cell Function and Interaction (58 papers). Their work is cited by papers focused on Immunology (13.4k citations), Molecular Biology (12.2k citations) and Oncology (5.4k citations). Authors at Novartis (Austria) collaborate with scholars in Austria, Switzerland and United States and have published in prestigious journals including Nature, New England Journal of Medicine and Cell. Some of Novartis (Austria)'s most productive authors include Antal Rot, Andreas Billich, J E de Vries, Thomas Baumruker, Ulrich H. von Andrian, Maria Grazia Roncarolo, Josef G. Meingassner, S. V. Antonenko, Mike Bigler and Matthieu Rouleau.

In The Last Decade

Novartis (Austria)

542 papers receiving 32.4k citations

Fields of papers published by authors at Novartis (Austria)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Novartis (Austria) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Novartis (Austria) at the time of their publication.

Countries citing scholars working at Novartis (Austria)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Novartis (Austria). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Novartis (Austria) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Novartis (Austria) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2026